Patrik Brundin

Roche (Switzerland) — Switzerland

Medicine · Health Sciences

113h-index49.0kcitations496works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(212), Nerve injury and regeneration(158), Neurological disorders and treatments(104), Neurogenesis and neuroplasticity mechanisms(95), Nuclear Receptors and Signaling(72)

Publications496 total

Genome-wide DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
Clinical Epigenetics·2026Open Access
In Memoriam: Dr. Einar Fredriksson, 1942–2025, founder of IOS Press
Journal of Parkinson s Disease·2025Open Access
Aggregation-prone alpha-synuclein proteoforms and dysregulated molecular signatures in the vermiform appendix of synucleinopathy patients
2025Open Access
Whole-genome DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
2025Open Access
Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model
Journal of Parkinson s Disease·2024· 2 citedOpen Access
<i>Tet2</i> loss suppress α-synuclein pathology by stimulating ciliogenesis
2024· 1 citedOpen Access
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
Journal of Parkinson s Disease·2024· 9 citedOpen Access
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
Cell Death and Disease·2024· 6 citedOpen Access
Correction: Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer’s disease
Acta Neuropathologica Communications·2024Open Access
Human Endogenous Retrovirus Expression is Dynamically Regulated in Parkinson’s Disease
2023· 6 citedOpen Access
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
Research Square (Research Square)·2023· 1 citedOpen Access
Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity
Heliyon·2023· 10 citedOpen Access
Urinary tract infections trigger synucleinopathy via the innate immune response
Acta Neuropathologica·2023· 22 citedOpen Access
Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis
npj Parkinson s Disease·2023· 33 citedOpen Access
Linking Immune Activation and Parkinson’s Disease
Journal of Parkinson s Disease·2022· 4 citedOpen Access
A novel automated morphological analysis of Iba1+ microglia using a deep learning assisted model
Frontiers in Cellular Neuroscience·2022· 16 citedOpen Access
Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala
eLife·2022· 33 citedOpen Access
Increased levels of circulating neurotoxic metabolites in patients with mild Covid19
2022· 2 citedOpen Access
Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
Brain Communications·2022· 50 citedOpen Access
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Movement Disorders·2022· 107 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Anders Björklund(14), Olle Lindvall(14), Stig Rehncrona(10), Håkan Widner(10), Jiayi Li(6), Nolwen L. Rey(6), Peter Hagell(5), Niall Quinn(5), Ronald Melki(5), David J. Brooks(5), Björn Gustavii(4), Élodie Angot(4), Jennifer A. Steiner(4), Paola Piccini(4), Caroline M. Tanner(3), Elisabet Englund(3), Julie Lotharius(3), G. V. Sawle(3), John C. Rothwell(3), C. D. Marsden(3)